FindTrial
Sign In

Procalcitonin as a predictor of the occurrence of acute respiratory distress syndrome (ARDS) after cardiac surgery with cardiopulmonary bypass (CPB)

Procalcitonin as a predictor of the occurrence of acute respiratory distress syndrome (ARDS) after cardiac surgery with cardiopulmonary bypass (CPB)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-14005076
Enrollment
Unknown
Registered
2014-07-20
Start date
2014-08-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Interventions

PCT elevated group:Nil
control group:Nil

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Age 18 years and above; 2) Programmed cardiac surgery under CPB; 3) Be free from active preoperative infection or inflammatory disease (meet all of the following criteria at study entry: leukocyte count less than 12*10^9/L, PCT less than 0.5ng/ml, body temperature lower than 37.5 degree); 4) Able to consent.

Exclusion criteria

Exclusion criteria: 1) History of chronic obstructive pulmonary disease (COPD), asthma or interstitial lung disease (ILD); 2) History of lung surgery; 3) Pregnant or lactating women; 4) Unwillingness of the patient to provide consent; 5) Enrolled in another trial.

Design outcomes

Primary

MeasureTime frame
Morbidity of ARD;—

Secondary

MeasureTime frame
The duration of mechanical ventilation;The length of ICU stay;Complications after surgery;—

Countries

China

Contacts

Public ContactRong-Guo Yu
garyyrg@yahoo.com+86 13805089943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 7, 2026